Literature DB >> 8995399

Molecular characterization of specific interactions between SHP-2 phosphatase and JAK tyrosine kinases.

T Yin1, R Shen, G S Feng, Y C Yang.   

Abstract

Interactions between SHP-2 phosphotyrosine phosphatase and JAK tyrosine kinases have recently been implicated in cytokine signal transduction. However, the molecular basis of these interactions is not well understood. In this study, we demonstrate that SHP-2 is tyrosine-phosphorylated by and associated with JAK1 and JAK2 but not JAK3 in COS-1 cell cotransfection experiments. SHP-2 phosphatase activity appears not to be required for JAK and SHP-2 interactions because SHP-2 with a mutation at amino acid 463 from Cys to Ser, which renders SHP-2 inactive, can still bind JAKs. We further demonstrate that SHP-2 SH2 domains (amino acids 1-209) are not essential for the association of JAKs with SHP-2, and the region between amino acids 232 and 272 in SHP-2 is important for the interactions. Furthermore, tyrosine residues 304 and 327 in SHP-2 are phosphorylated by JAKs, and phosphorylated SHP-2 can associate with the downstream adapter protein Grb2. Finally, deletion of the N terminus but not the kinase-like domain of JAK2 abolishes the association of JAK2 with SHP-2. Taken together, these studies identified novel sequences for SHP-2 and JAK interactions that suggest unique signaling mechanisms mediated by these two molecules.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8995399     DOI: 10.1074/jbc.272.2.1032

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

1.  Alternatively spliced, truncated GCSF receptor promotes leukemogenic properties and sensitivity to JAK inhibition.

Authors:  H M Mehta; M Futami; T Glaubach; D W Lee; J R Andolina; Q Yang; Z Whichard; M Quinn; H F Lu; W M Kao; B Przychodzen; C A Sarkar; A Minella; J P Maciejewski; S J Corey
Journal:  Leukemia       Date:  2013-10-30       Impact factor: 11.528

2.  Gab1 acts as an adapter molecule linking the cytokine receptor gp130 to ERK mitogen-activated protein kinase.

Authors:  M Takahashi-Tezuka; Y Yoshida; T Fukada; T Ohtani; Y Yamanaka; K Nishida; K Nakajima; M Hibi; T Hirano
Journal:  Mol Cell Biol       Date:  1998-07       Impact factor: 4.272

3.  A deletion mutation in the SH2-N domain of Shp-2 severely suppresses hematopoietic cell development.

Authors:  C K Qu; Z Q Shi; R Shen; F Y Tsai; S H Orkin; G S Feng
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

4.  Protein tyrosine phosphatase 2 (SHP-2) moderates signaling by gp130 but is not required for the induction of acute-phase plasma protein genes in hepatic cells.

Authors:  H Kim; T S Hawley; R G Hawley; H Baumann
Journal:  Mol Cell Biol       Date:  1998-03       Impact factor: 4.272

Review 5.  Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway.

Authors:  P C Heinrich; I Behrmann; G Müller-Newen; F Schaper; L Graeve
Journal:  Biochem J       Date:  1998-09-01       Impact factor: 3.857

Review 6.  Leptin Signaling in the Control of Metabolism and Appetite: Lessons from Animal Models.

Authors:  Alberto A Barrios-Correa; José A Estrada; Irazú Contreras
Journal:  J Mol Neurosci       Date:  2018-10-03       Impact factor: 3.444

7.  Activation of the protein tyrosine phosphatase SHP2 via the interleukin-6 signal transducing receptor protein gp130 requires tyrosine kinase Jak1 and limits acute-phase protein expression.

Authors:  F Schaper; C Gendo; M Eck; J Schmitz; C Grimm; D Anhuf; I M Kerr; P C Heinrich
Journal:  Biochem J       Date:  1998-11-01       Impact factor: 3.857

8.  Enzalutamide-Induced Feed-Forward Signaling Loop Promotes Therapy-Resistant Prostate Cancer Growth Providing an Exploitable Molecular Target for Jak2 Inhibitors.

Authors:  Vindhya Udhane; Cristina Maranto; David T Hoang; Lei Gu; Andrew Erickson; Savita Devi; Pooja G Talati; Anjishnu Banerjee; Kenneth A Iczkowski; Kenneth Jacobsohn; William A See; Tuomas Mirtti; Deepak Kilari; Marja T Nevalainen
Journal:  Mol Cancer Ther       Date:  2019-09-23       Impact factor: 6.261

9.  Lnk adaptor suppresses radiation resistance and radiation-induced B-cell malignancies by inhibiting IL-11 signaling.

Authors:  Igal Louria-Hayon; Catherine Frelin; Julie Ruston; Gerald Gish; Jing Jin; Michael M Kofler; Jean-Philippe Lambert; Hibret A Adissu; Michael Milyavsky; Robert Herrington; Mark D Minden; John E Dick; Anne-Claude Gingras; Norman N Iscove; Tony Pawson
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-02       Impact factor: 11.205

10.  Autophosphorylation of JAK2 on tyrosines 221 and 570 regulates its activity.

Authors:  Lawrence S Argetsinger; Jean-Louis K Kouadio; Hanno Steen; Allan Stensballe; Ole N Jensen; Christin Carter-Su
Journal:  Mol Cell Biol       Date:  2004-06       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.